The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients.

Liu, Ting-Hui; Wu, Jheng-Yan; Huang, Po-Yu; Tsai, Ya-Wen; Lai, Chih-Cheng

Liu, Ting-Hui; Wu, Jheng-Yan; Huang, Po-Yu; Tsai, Ya-Wen; Lai, Chih-Cheng.

Liu TH; Department of General Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Wu JY; Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan.
Huang PY; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Tsai YW; Center of Integrative Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Lai CC; Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address: dtmed141@gmail.com.

J Infect ; 86(3): 256-308, 2023 03.

Article in English | MEDLINE | ID: covidwho-2180660

Subject(s)

COVID-19; Epilepsy; Humans; Retrospective Studies; Ritonavir/adverse effects; COVID-19 Drug Treatment; Epilepsy/drug therapy; Epilepsy/epidemiology; Seizures/drug therapy; Seizures/epidemiology; Antiviral Agents/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Epilepsy / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Infect Year: 2023 Document Type: Article Affiliation country: J.jinf.2023.01.014

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google